<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35513421</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Hyperexcitability in young iPSC-derived C9ORF72 mutant motor neurons is associated with increased intracellular calcium release.</ArticleTitle><Pagination><StartPage>7378</StartPage><MedlinePgn>7378</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-09751-3</ELocationID><Abstract><AbstractText>A large hexanucleotide repeat expansion in the C9ORF72 gene is the most prevalent cause of amyotrophic lateral sclerosis (ALS). To better understand neuronal dysfunction during ALS progression, we studied motor neuron (MN) cultures derived from iPSC lines generated from C9ORF72 (C9) expansion carriers and unaffected controls. C9 and control MN cultures showed comparable mRNA levels for MN markers SMI-32, HB9 and ISL1 and similar MN yields (&gt;&#x2009;50% TUJ1/SMI-32 double-positive MNs). Using whole-cell patch clamp we showed that C9-MNs have normal membrane capacitance, resistance and resting potential. However, immature (day 40) C9-MNs exhibited a hyperexcitable phenotype concurrent with increased release of calcium (Ca<sup>2+</sup>) from internal stores, but with no changes to Na<sub>V</sub> and K<sub>V</sub> currents. Interestingly, this was a transient phenotype. By day 47, maturing C9-MNs demonstrated normal electrophysiological activity, displaying only subtle alterations on&#xa0;mitochondrial Ca<sup>2+</sup> release. Together, these findings suggest the potential importance of a developmental component to C9ORF72-related ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burley</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biology, University of St Andrews, North Haugh, St Andrews, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beccano-Kelly</LastName><ForeName>Dayne A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University of Cardiff, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talbot</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llana</LastName><ForeName>Oscar Cordero</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bristol Medical School, Translational Health Sciences, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wade-Martins</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK. richard.wade-martins@dpag.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P007058/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T041129/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N029453/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M024962/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WADE-MARTINS/OCT13/867-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_EX_MR/N50192X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L023784/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>5</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35513421</ArticleId><ArticleId IdType="pmc">PMC9072315</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-09751-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-09751-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/J.NEURON.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Rothstein JD. From charcot to lou gehrig: Deciphering selective motor neuron death in als. Nat. Rev. Neurosci. 2001;2(11):806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Siddique T, Fu R, Heckman CJ. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 2005 doi: 10.1113/jphysiol.2004.074138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.074138</ArticleId><ArticleId IdType="pmc">PMC1665614</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bories C, Amendola J, Lamotted&#x2019;Incamps B, Durand J. Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2007;25(2):451&#x2013;459. doi: 10.1111/j.1460-9568.2007.05306.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2007.05306.x</ArticleId><ArticleId IdType="pubmed">17284186</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ. Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 2011 doi: 10.1113/jphysiol.2010.200659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.200659</ArticleId><ArticleId IdType="pmc">PMC3098701</ArticleId><ArticleId IdType="pubmed">21486770</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Cazenave W, Cattaert D, Branchereau P. Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;54:116&#x2013;126. doi: 10.1016/j.nbd.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.011</ArticleId><ArticleId IdType="pubmed">23466698</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Higashihara M, Bos M, Geevasinga N, Kiernan MC, Vucic S. Cortical hyperexcitability evolves with disease progression in ALS. Ann. Clin. Transl. Neurol. 2020;7(5):733&#x2013;741. doi: 10.1002/acn3.51039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51039</ArticleId><ArticleId IdType="pmc">PMC7261748</ArticleId><ArticleId IdType="pubmed">32304186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131(6):1540&#x2013;1550. doi: 10.1093/brain/awn071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, Kuwabara S, Misawa S, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: Impaired potassium channel function related to disease stage. Brain. 2006;129(Pt 4):953&#x2013;962. doi: 10.1093/brain/awl024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl024</ArticleId><ArticleId IdType="pubmed">16467388</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90(3):521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Cabrera GT, Tran H, et al. Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron. 2015;88(5):902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Muhammad AKMG, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88(5):892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7(1):1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013;5:208. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin A-C, Burr K, Borooah S, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun. 2015;6(1):5999. doi: 10.1038/ncomms6999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6999</ArticleId><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj BT, Livesey MR, Zhao C, et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 2018;9(1):347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Scaber J, Ababneh N, et al. C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal demen. Stem Cells. 2016;34(8):2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z-W, Chen H, Liu H, et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 2015;6:6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean BP. The action potential in mammalian central neurons. Nat. Rev. Neurosci. 2007;8(6):451&#x2013;465. doi: 10.1038/nrn2148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2148</ArticleId><ArticleId IdType="pubmed">17514198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendahhou S. Keeping hyperactive voltage-gated sodium channels in silent mode. J. Physiol. 2012;590(11):2543&#x2013;2544. doi: 10.1113/jphysiol.2012.229310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2012.229310</ArticleId><ArticleId IdType="pmc">PMC3424708</ArticleId><ArticleId IdType="pubmed">22787162</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge MJ. Neuronal calcium signaling. Neuron. 1998;21(1):13&#x2013;26. doi: 10.1016/S0896-6273(00)80510-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80510-3</ArticleId><ArticleId IdType="pubmed">9697848</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao-min L, Theron HE. Characterization of ionomycin as a calciun ionophore. J. Biol. Chem. 1978;253(17):5892&#x2013;5894. doi: 10.1016/S0021-9258(17)34550-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)34550-7</ArticleId><ArticleId IdType="pubmed">28319</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2006;117(7):1458&#x2013;1466. doi: 10.1016/j.clinph.2006.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2006.04.016</ArticleId><ArticleId IdType="pubmed">16759905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostock H, Sharief MK, Reid G, Murray NMF. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain. 1995;118(1):217&#x2013;225. doi: 10.1093/brain/118.1.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/118.1.217</ArticleId><ArticleId IdType="pubmed">7534598</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Gomes CM. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front. Cell Neurosci. 2015;9(June):1&#x2013;6. doi: 10.3389/fncel.2015.00225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00225</ArticleId><ArticleId IdType="pmc">PMC4468822</ArticleId><ArticleId IdType="pubmed">26136661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Barbagallo P, Farrimond L, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD. Stem Cell Rep. 2020;14(5):892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, Livesey MR, McDade K, et al. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain. J. Pathol. 2020;250(1):67&#x2013;78. doi: 10.1002/path.5351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin A-C, Chouhan AK, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68(5):1046&#x2013;1064. doi: 10.1002/GLIA.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GLIA.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, Manfredi G. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech. Ageing Dev. 2010;131(7&#x2013;8):517&#x2013;526. doi: 10.1016/j.mad.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC2933290</ArticleId><ArticleId IdType="pubmed">20493207</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Barbagallo P, Talbot K. The role of mitochondrial dysfunction and ER stress in TDP-43 and C9ORF72 ALS. Front. Cell Neurosci. 2021 doi: 10.3389/FNCEL.2021.653688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNCEL.2021.653688</ArticleId><ArticleId IdType="pmc">PMC8047135</ArticleId><ArticleId IdType="pubmed">33867942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic V, Prell T, Lautenschlaeger J, Grosskreutz J. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front. Cell Neurosci. 2014 doi: 10.3389/FNCEL.2014.00147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNCEL.2014.00147</ArticleId><ArticleId IdType="pmc">PMC4039088</ArticleId><ArticleId IdType="pubmed">24910594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallings R, Connor-Robson N, Wade-Martins R. LRRK2 interacts with the vacuolar-type H +-ATPase pump a1 subunit to regulate lysosomal function. Hum. Mol. Genet. 2019;28(16):2696&#x2013;2710. doi: 10.1093/hmg/ddz088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz088</ArticleId><ArticleId IdType="pmc">PMC6687951</ArticleId><ArticleId IdType="pubmed">31039583</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>